1. Home
  2. HLNE vs ICUI Comparison

HLNE vs ICUI Comparison

Compare HLNE & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Lane Incorporated

HLNE

Hamilton Lane Incorporated

HOLD

Current Price

$103.29

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$179.34

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLNE
ICUI
Founded
1991
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.6B
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
HLNE
ICUI
Price
$103.29
$179.34
Analyst Decision
Buy
Strong Buy
Analyst Count
9
3
Target Price
$156.78
$169.00
AVG Volume (30 Days)
748.5K
327.6K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
2.44%
N/A
EPS Growth
41.64
100.62
EPS
3.98
1.96
Revenue
$758,993,000.00
$2,231,262,000.00
Revenue This Year
$9.69
N/A
Revenue Next Year
$15.81
$4.46
P/E Ratio
$26.34
$92.90
Revenue Growth
6.46
N/A
52 Week Low
$71.88
$111.42
52 Week High
$159.87
$192.85

Technical Indicators

Market Signals
Indicator
HLNE
ICUI
Relative Strength Index (RSI) 71.96 63.72
Support Level $90.31 $136.56
Resistance Level $105.34 N/A
Average True Range (ATR) 3.84 5.28
MACD 1.39 0.93
Stochastic Oscillator 89.76 59.46

Price Performance

Historical Comparison
HLNE
ICUI

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private markets investment firm globally, providing solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 750 professionals operating in offices throughout North America, Europe, Asia Pacific, and the Middle East. It has approximately $986 billion in assets under management and supervision, composed of nearly $141 billion in discretionary assets and more than $845 billion in non-discretionary assets. The group specializes in building flexible investment programs that provide clients access to the full spectrum of private markets strategies, sectors, and geographies.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: